Chronic graft-versus-host disease: Sanofi, CEMKA, Lifen and SFGM-TC join forces to provide a better understanding of patients' care pathways
Chronic graft-versus-host disease: Sanofi, CEMKA, Lifen and SFGM-TC join forces to provide a better understanding of patients' care pathways
Chronic graft-versus-host disease: Sanofi, CEMKA, Lifen and SFGM-TC join forces to provide a better understanding of patients' care pathways
.png)
